XYLO is pioneering next-generation therapeutics using advanced neuroscience and computational drug discovery to rewire neural circuits and restore brain function. Our mission is to deliver breakthrough therapies that address critical unmet needs and improve the lives of patients worldwide.
Headquarters:
United States of America
Company Type:
SME
Company size:
11-50 Employees
Address:
3415 COLORADO AVE; BOULDER, COLORADO 80303, US
At a glanceLOW
spending power
